Fact CheckerSign in

NCT06550674Recruiting

Identification of New Candidate Genes for Hereditary Predisposition to Uveal Melanoma

Source: ClinicalTrials.gov · Last updated 19 Mar 2026

Brief summary (registry, in English)

Only 20% of familial uveal melanomas are explained by a hereditary predisposition, implying the presence of as yet unknown hereditary predispositions. This hypothesis is reinforced by epidemiological studies revealing an excess risk of prostate cancer, thyroid cancer and leukemia in patients who have developed uveal melanoma, even though these cancers are not part of the tumor spectrum of known hereditary predispositions to uveal melanoma (BAP1, MBD4). The identification of new candidate genes, once validated, would enable us to offer these families appropriate surveillance.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
50 (estimated)
First submitted
5 Aug 2024
Start date
29 Oct 2024
Primary completion date
Apr 2028
Lead sponsor
Centre Jean Perrin
Diseases
Melanoma
NCT number
NCT06550674

What you commit to

  • Study type: Interventional
  • Planned participants: 50
  • From 29 Oct 2024 to the primary completion date, Apr 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Causal pathogenic variation identified in BAP1 or MBD4
  • Patient does not consent to constitutional genetic analysis for diagnostic purposes
  • Patient not consenting to a constitutional genetic analysis for research purposes
  • Pregnant and breast-feeding women
  • Patients under guardianship or trusteeship

Who the study is looking for

  • Patient with a personal history of uveal melanoma (newly diagnosed, under treatment or in follow-up)
  • Enrolled in or benefiting from a social security scheme

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Centre Jean Perrin
Coordinator of this site? Confirm its status
Clermont-FerrandFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.